{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:52:44Z","timestamp":1789469564958,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T00:00:00Z","timestamp":1372896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/npp.2013.165","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T09:45:47Z","timestamp":1372931147000},"page":"2568-2577","source":"Crossref","is-referenced-by-count":86,"title":["Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis"],"prefix":"10.1038","volume":"38","author":[{"name":"From the FLAMM-PEPs study\u2014Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental (CIBERSAM)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Bioque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Garc\u00eda-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina S","family":"MacDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Meseguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar A","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gonzalez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rodriguez-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C","family":"Leza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,4]]},"reference":[{"key":"BFnpp2013165_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/archpsyc.60.6.565","volume":"60","author":"A Aleman","year":"2003","unstructured":"Aleman A, Kahn RS, Selten JP (2003). Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry 60: 565\u2013571.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2013165_CR2","unstructured":"American Psychiatric Association (1994) DSM-IV: Diagnostic and Statistical Manual of Mental Disorders 4th edn. American Psychiatric Association: Washington, DC."},{"key":"BFnpp2013165_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2007.11.029","volume":"99","author":"SS Bangalore","year":"2008","unstructured":"Bangalore SS, Prasad KM, Montrose DM, Goradia DD, Diwadkar VA, Keshavan MS (2008). Cannabis use and brain structural alterations in first episode schizophrenia\u2014a region of interest, voxel based morphometric study. Schizophr Res 99: 1\u20136.","journal-title":"Schizophr Res"},{"key":"BFnpp2013165_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2012.01.014","volume":"355","author":"N Battista","year":"2012","unstructured":"Battista N, Meccariello R, Cobellis G, Fasano S, Di Tommaso M, Pirazzi V et al (2012). The role of endocannabinoids in gonadal function and fertility along the evolutionary axis. Mol Cell Endocrinol 355: 1\u201314.","journal-title":"Mol Cell Endocrinol"},{"key":"BFnpp2013165_CR5","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1523\/JNEUROSCI.20-09-03401.2000","volume":"20","author":"M Beltramo","year":"2000","unstructured":"Beltramo M, de Fonseca FR, Navarro M, Calignano A, Gorriti MA, Grammatikopoulos G et al (2000). Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J Neurosci 20: 3401\u20133407.","journal-title":"J Neurosci"},{"issue":"Suppl 3","key":"BFnpp2013165_CR6","first-page":"15","volume":"38","author":"M Bernardo","year":"2010","unstructured":"Bernardo M, Bioque M (2010). Schizophrenia: from neurobiology to nosology of mental disorders. Actas Esp Psiquiatr 38 (Suppl 3): 15\u201317.","journal-title":"Actas Esp Psiquiatr"},{"key":"BFnpp2013165_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.rpsm.2012.11.001","volume":"6","author":"M Bernardo","year":"2013","unstructured":"Bernardo M, Bioque M, Parellada M, Saiz Ruiz J, Cuesta MJ, Llerena A et al (2013). Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs). Rev Psiquiatr Salud Ment 6: 4\u201316.","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"BFnpp2013165_CR8","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1098\/rstb.2011.0388","volume":"367","author":"A Bilkei-Gorzo","year":"2012","unstructured":"Bilkei-Gorzo A (2012). The endocannabinoid system in normal and pathological brain ageing. Philos Trans R Soc Lond B Biol Sci 367: 3326\u20133341.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFnpp2013165_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.schres.2011.11.009","volume":"134","author":"DL Boggs","year":"2012","unstructured":"Boggs DL, Kelly DL, McMahon RP, Gold JM, Gorelick DA, Linthicum J et al (2012). Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial. Schizophr Res 134: 207\u2013210.","journal-title":"Schizophr Res"},{"key":"BFnpp2013165_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","volume":"57","author":"A Caspi","year":"2005","unstructured":"Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H et al (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57: 1117\u20131127.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013165_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/cap.2007.0138","volume":"18","author":"J Castro-Fornieles","year":"2008","unstructured":"Castro-Fornieles J, Parellada M, Soutullo CA, Baeza I, Gonzalez-Pinto A, Graell M et al (2008). Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach. J Child Adolesc Psychopharmacol 18: 327\u2013336.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"BFnpp2013165_CR12","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.2174\/138161208785740018","volume":"14","author":"D Centonze","year":"2008","unstructured":"Centonze D, Battistini L, Maccarrone M (2008). The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases. Curr Pharm Des 14: 2370\u20132442.","journal-title":"Curr Pharm Des"},{"key":"BFnpp2013165_CR13","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1124\/mol.110.068304","volume":"78","author":"PK Chanda","year":"2010","unstructured":"Chanda PK, Gao Y, Mark L, Btesh J, Strassle BW, Lu P et al (2010). Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Mol Pharmacol 78: 996\u20131003.","journal-title":"Mol Pharmacol"},{"key":"BFnpp2013165_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00406-009-0024-2","volume":"259","author":"DC D'Souza","year":"2009","unstructured":"D'Souza DC, Sewell RA, Ranganathan M (2009). Cannabis and psychosis\/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci 259: 413\u2013431.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BFnpp2013165_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-511X-2-5","volume":"2","author":"N De Marchi","year":"2003","unstructured":"De Marchi N, De Petrocellis L, Orlando P, Daniele F, Fezza F, Di Marzo V (2003). Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis 2: 5.","journal-title":"Lipids Health Dis"},{"key":"BFnpp2013165_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fpsyt.2012.00085","volume":"3","author":"J Desfosses","year":"2012","unstructured":"Desfosses J, Stip E, Bentaleb LA, Lipp O, Chiasson JP, Furtos A et al (2012). Plasma endocannabinoid alterations in individuals with substance use disorder are dependent on the \"Mirror Effect\" of schizophrenia. Front Psychiatry 3: 85.","journal-title":"Front Psychiatry"},{"key":"BFnpp2013165_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/35071088","volume":"410","author":"V Di Marzo","year":"2001","unstructured":"Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z et al (2001). Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822\u2013825.","journal-title":"Nature"},{"key":"BFnpp2013165_CR18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","volume":"65","author":"SM Eggan","year":"2008","unstructured":"Eggan SM, Hashimoto T, Lewis DA (2008). Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry 65: 772\u2013784.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2013165_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","volume":"33","author":"J Endicott","year":"1976","unstructured":"Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33: 766\u2013771.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2013165_CR20","volume-title":"Entrevista Cl\u00ednica Estructurada Para los Trastornos del eje-I del DSM-IV","author":"M First","year":"1999","unstructured":"First M, Spitzer R, Gibbon M, Williams J (eds) (1999) Entrevista Cl\u00ednica Estructurada Para los Trastornos del eje-I del DSM-IV. Masson: Barcelona."},{"key":"BFnpp2013165_CR21","doi-asserted-by":"publisher","unstructured":"Frodl T, Amico F (2013). Is there an association between peripheral immune markers and structural\/functional neuroimaging findings? Prog Neuropsychopharmacol Biol Psychiatry ( http:\/\/dx.doi.org\/10.1016\/j.pnpbp.2012.12.013 ).","DOI":"10.1016\/j.pnpbp.2012.12.013"},{"key":"BFnpp2013165_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3410\/M5-2","volume":"5","author":"SH Gage","year":"2013","unstructured":"Gage SH, Zammit S, Hickman M (2013). Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. F1000 Med Rep 5: 2.","journal-title":"F1000 Med Rep"},{"key":"BFnpp2013165_CR23","unstructured":"Garcia-Bueno B, Bioque M, Mac-Dowell KS, Barcones MF, Martinez-Cengotitabengoa M, Pina-Camacho L et al (2013). Pro-\/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull (e-pub ahead of print 13 March 2013)."},{"key":"BFnpp2013165_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.psychres.2011.08.014","volume":"198","author":"C Garcia-Rizo","year":"2012","unstructured":"Garcia-Rizo C, Fernandez-Egea E, Oliveira C, Justicia A, Bernardo M, Kirkpatrick B (2012). Inflammatory markers in antipsychotic-naive patients with nonaffective psychosis and deficit vs. nondeficit features. Psychiatry Res 198: 212\u2013215.","journal-title":"Psychiatry Res"},{"key":"BFnpp2013165_CR25","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ (2010). International consensus study of antipsychotic dosing. Am J Psychiatry 167: 686\u2013693.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2013165_CR26","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","volume":"29","author":"A Giuffrida","year":"2004","unstructured":"Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J et al (2004). Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 29: 2108\u20132114.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013165_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pnpbp.2012.04.002","volume":"38","author":"A Giuffrida","year":"2012","unstructured":"Giuffrida A, Seillier A (2012). New insights on endocannabinoid transmission in psychomotor disorders. Prog Neuropsychopharmacol Biol Psychiatry 38: 51\u201358.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2013165_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/schbul\/sbi027","volume":"31","author":"C Henquet","year":"2005","unstructured":"Henquet C, Murray R, Linszen D, van Os J (2005). The environment and schizophrenia: the role of cannabis use. Schizophr Bull 31: 608\u2013612.","journal-title":"Schizophr Bull"},{"key":"BFnpp2013165_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuroscience.2011.11.020","volume":"204","author":"CJ Hillard","year":"2012","unstructured":"Hillard CJ, Weinlander KM, Stuhr KL (2012). Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience 204: 207\u2013229.","journal-title":"Neuroscience"},{"key":"BFnpp2013165_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.schres.2011.02.021","volume":"128","author":"BC Ho","year":"2011","unstructured":"Ho BC, Wassink TH, Ziebell S, Andreasen NC (2011). Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res 128: 66\u201375.","journal-title":"Schizophr Res"},{"key":"BFnpp2013165_CR31","doi-asserted-by":"publisher","DOI":"10.1037\/10645-000","volume-title":"Social Class and Mental Illness","author":"AB Hollingshead","year":"1958","unstructured":"Hollingshead AB, Redlich FC (eds) (1958) Social Class and Mental Illness. Wiley: New York."},{"key":"BFnpp2013165_CR32","volume-title":"IBM SPSS Statistics for Windows","author":"Corp IBM","year":"2011","unstructured":"IBM Corp (2011) IBM SPSS Statistics for Windows. IBM Corp.: Armonk, NY."},{"key":"BFnpp2013165_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature09552","volume":"468","author":"TR Insel","year":"2010","unstructured":"Insel TR (2010). Rethinking schizophrenia. Nature 468: 187\u2013193.","journal-title":"Nature"},{"key":"BFnpp2013165_CR34","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.biopsych.2009.09.024","volume":"67","author":"H Ishiguro","year":"2010","unstructured":"Ishiguro H, Horiuchi Y, Ishikawa M, Koga M, Imai K, Suzuki Y et al (2010). Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry 67: 974\u2013982.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013165_CR35","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","volume":"371","author":"RS Kahn","year":"2008","unstructured":"Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP et al (2008). Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371: 1085\u20131097.","journal-title":"Lancet"},{"key":"BFnpp2013165_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261\u2013276.","journal-title":"Schizophr Bull"},{"key":"BFnpp2013165_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1888-9891(09)72400-0","volume":"2","author":"B Kirkpatrick","year":"2009","unstructured":"Kirkpatrick B (2009). The Concept of Schizophrenia. Rev Psiquiatr Salud Ment 2: 105\u2013107.","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"BFnpp2013165_CR38","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1189\/jlb.0303101","volume":"74","author":"TW Klein","year":"2003","unstructured":"Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L et al (2003). The cannabinoid system and immune modulation. J Leukoc Biol 74: 486\u2013496.","journal-title":"J Leukoc Biol"},{"key":"BFnpp2013165_CR39","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1192\/bjp.bp.108.053843","volume":"194","author":"D Koethe","year":"2009","unstructured":"Koethe D, Giuffrida A, Schreiber D, Hellmich M, Schultze-Lutter F, Ruhrmann S et al (2009). Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis. Br J Psychiatry 194: 371\u2013372.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2013165_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000259089","volume":"1","author":"A Kokkevi","year":"1995","unstructured":"Kokkevi A, Hartgers C (1995). EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res 1: 208\u2013210.","journal-title":"Eur Addict Res"},{"key":"BFnpp2013165_CR41","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/schbul\/sbp031","volume":"36","author":"J Koskinen","year":"2009","unstructured":"Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J (2009). Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 36: 1115\u20131130.","journal-title":"Schizophr Bull"},{"key":"BFnpp2013165_CR42","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.lfs.2012.08.023","volume":"92","author":"MF Lazenka","year":"2012","unstructured":"Lazenka MF, Selley DE, Sim-Selley LJ (2012). Brain regional differences in CB1 receptor adaptation and regulation of transcription. Life Sci 92: 446\u2013452.","journal-title":"Life Sci"},{"key":"BFnpp2013165_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/09513590410001692492","volume":"18","author":"N Lazzarin","year":"2004","unstructured":"Lazzarin N, Valensise H, Bari M, Ubaldi F, Battista N, Finazzi-Agro A et al (2004). Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. Gynecol Endocrinol 18: 212\u2013218.","journal-title":"Gynecol Endocrinol"},{"key":"BFnpp2013165_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","volume":"94","author":"FM Leweke","year":"2007","unstructured":"Leweke FM, Giuffrida A, Koethe D, Schreiber D, Nolden BM, Kranaster L et al (2007). Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophr Res 94: 29\u201336.","journal-title":"Schizophr Res"},{"key":"BFnpp2013165_CR45","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","volume":"10","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D (1999). Elevated endogenous cannabinoids in schizophrenia. Neuroreport 10: 1665\u20131669.","journal-title":"Neuroreport"},{"key":"BFnpp2013165_CR46","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/tp.2012.15","volume":"2","author":"FM Leweke","year":"2012","unstructured":"Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C et al (2012). Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry 2: e94.","journal-title":"Transl Psychiatry"},{"key":"BFnpp2013165_CR47","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.410240415","volume":"24","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988). Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24: 574\u2013576.","journal-title":"Ann Neurol"},{"key":"BFnpp2013165_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1741-7015-2-13","volume":"2","author":"J McGrath","year":"2004","unstructured":"McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2: 13.","journal-title":"BMC Med"},{"key":"BFnpp2013165_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pharmthera.2011.06.003","volume":"132","author":"U Meyer","year":"2011","unstructured":"Meyer U, Schwarz MJ, Muller N (2011). Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative\/cognitive symptoms and beyond. Pharmacol Ther 132: 96\u2013110.","journal-title":"Pharmacol Ther"},{"key":"BFnpp2013165_CR50","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382\u2013389.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2013165_CR51","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"TH Moore","year":"2007","unstructured":"Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M et al (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319\u2013328.","journal-title":"Lancet"},{"key":"BFnpp2013165_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0165-5728(02)00113-3","volume":"127","author":"L Nong","year":"2002","unstructured":"Nong L, Newton C, Cheng Q, Friedman H, Roth MD, Klein TW (2002). Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers. J Neuroimmunol 127: 169\u2013176.","journal-title":"J Neuroimmunol"},{"key":"BFnpp2013165_CR53","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/npp.2011.34","volume":"36","author":"A Ortega-Alvaro","year":"2011","unstructured":"Ortega-Alvaro A, Aracil-Fernandez A, Garcia-Gutierrez MS, Navarrete F, Manzanares J (2011). Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology 36: 1489\u20131504.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013165_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nri2015","volume":"7","author":"VH Perry","year":"2007","unstructured":"Perry VH, Cunningham C, Holmes C (2007). Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 7: 161\u2013167.","journal-title":"Nat Rev Immunol"},{"key":"BFnpp2013165_CR55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ajmg.b.31062","volume":"153B","author":"B Rollins","year":"2010","unstructured":"Rollins B, Martin MV, Morgan L, Vawter MP (2010). Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 153B: 919\u2013936.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFnpp2013165_CR56","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/mp.2011.42","volume":"17","author":"E Schwarz","year":"2012","unstructured":"Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM et al (2012). Identification of a biological signature for schizophrenia in serum. Mol Psychiatry 17: 494\u2013502.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2013165_CR57","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1017\/S146114570999023X","volume":"13","author":"A Seillier","year":"2010","unstructured":"Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A (2010). Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats. Int J Neuropsychopharmacol 13: 373\u2013386.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2013165_CR58","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/archpsyc.1983.01790100074010","volume":"40","author":"D Shaffer","year":"1983","unstructured":"Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H et al (1983). A children's global assessment scale (CGAS). Arch Gen Psychiatry 40: 1228\u20131231.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2013165_CR59","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.eurpsy.2009.01.002","volume":"24","author":"G Sugranyes","year":"2009","unstructured":"Sugranyes G, Flamarique I, Parellada E, Baeza I, Goti J, Fernandez-Egea E et al (2009). Cannabis use and age of diagnosis of schizophrenia. Eur Psychiatry 24: 282\u2013286.","journal-title":"Eur Psychiatry"},{"key":"BFnpp2013165_CR60","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/schbul\/sbs043","volume":"38","author":"EF Torrey","year":"2012","unstructured":"Torrey EF, Bartko JJ, Yolken RH (2012). Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 38: 642\u2013647.","journal-title":"Schizophr Bull"},{"key":"BFnpp2013165_CR61","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/schbul\/sbp016","volume":"35","author":"ND Volkow","year":"2009","unstructured":"Volkow ND (2009). Substance use disorders in schizophrenia\u2014clinical implications of comorbidity. Schizophr Bull 35: 469\u2013472.","journal-title":"Schizophr Bull"},{"key":"BFnpp2013165_CR62","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.2174\/138161208785740090","volume":"14","author":"SA Wolf","year":"2008","unstructured":"Wolf SA, Tauber S, Ullrich O (2008). CNS immune surveillance and neuroinflammation: endocannabinoids keep control. Curr Pharm Des 14: 2266\u20132278.","journal-title":"Curr Pharm Des"},{"key":"BFnpp2013165_CR63","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA (1978). A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133: 429\u2013435.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2013165_CR64","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.2174\/138161212802884744","volume":"18","author":"E Zamberletti","year":"2012","unstructured":"Zamberletti E, Rubino T, Parolaro D (2012). The endocannabinoid system and schizophrenia: integration of evidence. Curr Pharm Des 18: 4980\u20134990.","journal-title":"Curr Pharm Des"},{"key":"BFnpp2013165_CR65","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/npp.2010.214","volume":"36","author":"S Zoppi","year":"2011","unstructured":"Zoppi S, Perez Nievas BG, Madrigal JL, Manzanares J, Leza JC, Garcia-Bueno B (2011). Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychopharmacology 36: 805\u2013818.","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2013165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T21:26:47Z","timestamp":1715635607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2013165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,4]]},"references-count":65,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["BFnpp2013165"],"URL":"https:\/\/doi.org\/10.1038\/npp.2013.165","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,4]]}}}